Guillemin Francis, Carruthers Erin, Li Linda C
University of Lorraine, EA 4360 APEMAC, Nancy F-54500, France.
Arthritis Research Centre of Canada, Richmond, BC, Canada.
Best Pract Res Clin Rheumatol. 2014 Jun;28(3):411-33. doi: 10.1016/j.berh.2014.08.001. Epub 2014 Sep 8.
Even in most egalitarian societies, disparities in care exist to the disadvantage of some people with chronic musculoskeletal (MSK) disorders and related disability. These situations translate into inequality in health and health outcomes. The goal of this chapter is to review concepts and determinants associated with health inequity, and the effect of interventions to minimize their impact. Health inequities are avoidable, unnecessary, unfair and unjust. Inequities can occur across the health care continuum, from primary and secondary prevention to diagnosis and treatment. There are many ways to define and identify inequities, according for instance to ethical, philosophical, epidemiological, sociological, economic, or public health points of view. These complementary views can be applied to set a framework of analysis, identify determinants and suggest targets of action against inequity. Most determinants of inequity in MSK disorders are similar to those in the general population and other chronic diseases. People may be exposed to inequity as a result of policies and rules set by the health care system, individuals' demographic characteristics (e.g., education level), or some behavior of health professionals and of patients. Osteoarthritis (OA) represents a typical chronic MSK condition. The PROGRESS-Plus framework is useful for identifying the important role that place of residence, race and ethnicity, occupation, gender, education, socioeconomic status, social capital and networks, age, disability and sexual orientation may have in creating or maintaining inequities in this disease. In rheumatoid arthritis (RA), a consideration of international data led to the conclusion that not all RA patients who needed biologic therapy had access to it. The disparity in care was due partly to policies of a country and a health care system, or economic conditions. We conclude this chapter by discussing examples of interventions designed for reducing health inequity.
即使在多数平等主义社会中,医疗保健方面的差异依然存在,这对一些患有慢性肌肉骨骼疾病(MSK)及相关残疾的人群不利。这些情况导致了健康及健康结果方面的不平等。本章的目的是回顾与健康不平等相关的概念和决定因素,以及为尽量减少其影响而采取的干预措施的效果。健康不平等是可避免、不必要、不公平且不公正的。不平等现象可能出现在整个医疗保健连续过程中,从一级和二级预防到诊断和治疗。定义和识别不平等的方法有很多,例如从伦理、哲学、流行病学、社会学、经济学或公共卫生的角度。这些互补的观点可用于建立一个分析框架、识别决定因素并提出消除不平等现象的行动目标。MSK疾病不平等现象的大多数决定因素与普通人群及其他慢性病的决定因素相似。人们可能由于医疗保健系统制定的政策和规则、个人的人口统计学特征(如教育水平),或医疗专业人员和患者的某些行为而面临不平等。骨关节炎(OA)是一种典型的慢性MSK疾病。PROGRESS-Plus框架有助于识别居住地、种族和民族、职业、性别、教育、社会经济地位、社会资本和网络、年龄、残疾和性取向在造成或维持该疾病不平等方面可能发挥的重要作用。在类风湿关节炎(RA)方面,对国际数据的考量得出结论,并非所有需要生物疗法的RA患者都能获得该疗法。医疗保健方面的差异部分归因于一个国家的政策、医疗保健系统或经济状况。我们通过讨论旨在减少健康不平等的干预措施示例来结束本章。